Abstract

BackgroundGastric diseases are a worldwide problem in modern society, as reported in the USA, in the range of 0.5–2 episodes/year/person and an incidence of 5–100 episodes/1000/week according to seasons and age. There is convincing evidence that oxidative stress is involved in the pathogenesis of acute gastric injury. Acid secreted from gastric parietal cells determines mucosal injuries which in turn cause inflammation and oxidative stress. Consequent inflammation produces free radicals by mitochondria thus causing lipid peroxidation, oxidative and acidic stress, which can lead to cell apoptosis. Vitamin D3, the active form of vitamin D, may counteract intracellular cell death and improve epithelial regeneration.MethodsThis study was planned to assess whether vitamin D3 is a protective factor against acid injury and oxidative stress in gastric epithelial cells. Primary epithelial cells and GTL-16 cells have been used to test the effects of Grisù® alone or in combination with vitamin D3 during oxidative stress or high acid exposition measuring cell viability, ROS production, cellular adhesion time along with apoptotic, autophagic and survival pathways. The combined effect of Grisù® and vitamin D3 was found more effective in counteracting the negative consequences of oxidative stress and acidity conditions than some other gastroprotective agents, such as Maalox® or Gaviscon®.ResultsIn case of oxidative stress or acidity condition the stimulation with Grisù® alone caused an improvement of cell viability and a reduction of ROS production on epithelial gastric cells. In addition, the adhesion time of the cells was improved. All these effects were increased by the presence of vitamin D3. Similar data were also observed in primary gastric epithelial cells confirming the results obtained in GTL-16 cells.ConclusionsThese results suggest that Grisù® in combination with vitamin D3 may exert a gastroprotective effect to maintain or restore the integrity of gastric epithelium through an antioxidant pathway, inhibiting apoptosis and activating survival kinases. Moreover, the combination of Grisù® and vitamin D3 improves cell viability and decreases ROS production compared to other gastroprotective agents combined with vitamin D3. All these data were validated using primary cells isolated from gastric tissue.Electronic supplementary materialThe online version of this article (doi:10.1186/s12876-016-0543-z) contains supplementary material, which is available to authorized users.

Highlights

  • Gastric diseases are a worldwide problem in modern society, as reported in the USA, in the range of 0.5–2 episodes/year/person and an incidence of 5–100 episodes/1000/week according to seasons and age

  • HCl enhances the process of lipid peroxidation in gastric mucosa [17]; the dissipation of mitochondrial transmembrane potential induces the production of reactive oxygen species (ROS) by mitochondria causing lipid peroxidation [18, 19]

  • Gastric epithelium is exposed to high levels of ROS, derived from physical, chemical, or microbiological agents existing in gastric lumen, far higher than in other tissues or biological fluids [22, 23]

Read more

Summary

Introduction

Gastric diseases are a worldwide problem in modern society, as reported in the USA, in the range of 0.5–2 episodes/year/person and an incidence of 5–100 episodes/1000/week according to seasons and age. Acid secreted from gastric parietal cells determines mucosal injuries which in turn cause inflammation and oxidative stress. Consequent inflammation produces free radicals by mitochondria causing lipid peroxidation, oxidative and acidic stress, which can lead to cell apoptosis. The cytoprotective functions against damage may be accomplished in the early phase of epithelial repair known as restitution [5,6,7], which is the ability of epithelial cells to spread and migrate across the basement membrane to repair the damage This event is the basis of repair of mucosae after injury and is an important element to grant continuity over broad areas within hours [8, 9]. Gastric acid (HCl) secreted from gastric parietal cells has been reported to determine gastric mucosal injuries such as peptic ulcer and to induce gastropathy [12]. When the lower esophageal sphincter is weak, the acid unnaturally moves up into the esophagus, causing gastroesophageal reflux disease (GERD), whose cardinal symptom is heartburn, mainly occurring postprandially

Objectives
Methods
Results
Discussion
Conclusion
Full Text
Paper version not known

Talk to us

Join us for a 30 min session where you can share your feedback and ask us any queries you have

Schedule a call

Disclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.